EquityFlow
›
Companies
› Insempra
Insempra
Biotech
· Munich, DE
Platform to produce sustainable biodegradable materials
Funding history
Date
Round
Amount
May 2024
Funding round
Munich biotech Insempra (formerly Origin.Bio) raised USD 20M from Henkel dx Ventures, Bayern Kapital and others.
$20M
Investors
Henkel dx Ventures
Similar companies in Biotech
Imperagen
Haga Bioscience
Pixelgen Technologies
Gallant
Chai Discovery
SNIPR Biome
Cellbox Labs
Scope Biosciences
GenLumina
Actithera
NUCLIDIUM
Anocca
Explore funding flow on EquityFlow →